Global Health Technologies Coalition’s “Breakthroughs”: WHO Executive Board agrees on set-up of pooled fund for global health R&D
“In this guest post, Alexandra Heumber — head of policy affairs at the Drugs for Neglected Diseases initiative — discusses actions taken during the World Health Organization (WHO)’s Executive Board meeting which could impact financing for the research and development (R&D) of new health technologies for developing countries…” (Chmiola, 2/6).